Is lack of goal-conflict-specific rhythmicity a biomarker for treatment resistance in generalised anxiety but not social anxiety or major depression?
Journal of Psychopharmacology · 2024
DOI: 10.1177/02698811241275627 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Psychopharmacology, 2024. Verfasst von Shabah M Shadli und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychology, University of Otago, Dunedin, New Zealand. Hauptthemen laut MEDLINE: Major Depressive Disorder, Electroencephalography, Biomarkers, Anxiety Disorders. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health Research Council of New Zealand.
Themen: Depression
Abstract (Originalsprache)
Background
Anxiety and depression cause major detriment to the patient, family, and society – particularly in treatment-resistant (TR) cases, which are highly prevalent. TR prevalence may be due to current diagnoses being based not on biological measures but on symptom lists that suffer from clinical subjectivity, variation in symptom presentation, and comorbidity.
Aims
Goal-conflict-specific rhythmicity (GCSR) measured using the Stop-Signal Task (SST) may provide the first neural biomarker for an anxiety process and disorder. This GCSR has been validated with selective drugs for anxiety. So, we proposed that GCSR could differ between TR and non-TR individuals and do so differently between those diagnoses normally sensitive to selective anxiolytics and those not.
Methods
We recorded electroencephalograms (EEG) from 20 TR participants (4 GAD, 5 SAD and 11 MDD) and 24 non-TR participants (4 GAD, 5 SAD and 15 Comorbid GAD/MDD (GMD)) while they performed the SST.
Results
There was significant positive GCSR in all groups except the GAD-TR group. GAD-TR lacked GCSR in the low-frequency range. However, TR had little effect in SAD or MDD/GMD populations with apparent increases not decreases.
Conclusions
Overall, these results suggest that GAD may occur in two forms: one resulting from excessive GCSR and so being drug sensitive, and the other resulting from some other mechanism and so being TR. In SAD and MDD groups, heightened GCSR could be a consequence rather than the cause, driven by mechanisms that are normally more sensitive to non-selective panicolytic antidepressants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychology, University of Otago, Dunedin, New Zealand.
- School of Psychology, Charles Sturt University, Bathurst, NSW, Australia.
- School of Psychology, University of Auckland, Auckland, New Zealand.
- School of Pharmacy, University of Otago, Dunedin, New Zealand.
- Department of Psychological Medicine, University of Otago, Dunedin, New Zealand.
ORCID-Profile: Paul Glue, Neil McNaughton
Förderung
- Health Research Council of New Zealand
Zitieren
APA
Shadli, S. M., Donegan, C. J., Bin Mohd Fahmi, M. S., Russell, B. R., Glue, P., & McNaughton, N. (2024). Is lack of goal-conflict-specific rhythmicity a biomarker for treatment resistance in generalised anxiety but not social anxiety or major depression?. Journal of Psychopharmacology. https://doi.org/10.1177/02698811241275627
Vancouver
Shadli SM, Donegan CJ, Bin Mohd Fahmi MS, Russell BR, Glue P, McNaughton N. Is lack of goal-conflict-specific rhythmicity a biomarker for treatment resistance in generalised anxiety but not social anxiety or major depression?. Journal of Psychopharmacology. 2024. doi:10.1177/02698811241275627
BibTeX
@article{Shadli2024,
author = {Shadli, Shabah M and Donegan, Carina J and Bin Mohd Fahmi, Muhammad Ss and Russell, Bruce R and Glue, Paul and McNaughton, Neil},
title = {Is lack of goal-conflict-specific rhythmicity a biomarker for treatment resistance in generalised anxiety but not social anxiety or major depression?},
journal = {Journal of Psychopharmacology},
year = {2024},
doi = {10.1177/02698811241275627}
}
EUVIMED